• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外生物等效性试验。

In vitro bioequivalence testing.

作者信息

Chow Shein-Chung, Shao Jun, Wang Hansheng

机构信息

Statplus Inc, Heston Hall, Suite 206, 1790 Yardley-Langhorne Road, Yardley, PA 19067, USA.

出版信息

Stat Med. 2003 Jan 15;22(1):55-68. doi: 10.1002/sim.1345.

DOI:10.1002/sim.1345
PMID:12486751
Abstract

A statistical test is proposed for in vitro bioequivalence testing between drug products such as nasal aerosols and nasal sprays. The proposed test generalizes the one recommended in the FDA 1999 guidance to the situation where replicated observations obtained from each sampled canister or bottle of the drug product are available. The technique developed by Hyslop, Hsuan and Holder is used so that the proposed test is asymptotically accurate. The type I error probability and power of the proposed test are investigated through a simulation study. A method for determining the required sample size to achieve a desired power is also proposed. A numerical example is given for illustration.

摘要

提出了一种用于鼻用气雾剂和鼻喷雾剂等药品体外生物等效性测试的统计检验方法。所提出的检验方法将美国食品药品监督管理局(FDA)1999年指南中推荐的方法推广到了这样一种情形:从药品的每个采样罐或瓶中获得了重复观测值。采用了由希斯洛普、宣和霍尔德开发的技术,以使所提出的检验在渐近意义上是准确的。通过模拟研究考察了所提出检验的I型错误概率和功效。还提出了一种确定达到期望功效所需样本量的方法。给出了一个数值例子进行说明。

相似文献

1
In vitro bioequivalence testing.体外生物等效性试验。
Stat Med. 2003 Jan 15;22(1):55-68. doi: 10.1002/sim.1345.
2
A modified large sample approach in the assessment of population bioequivalence.一种用于评估群体生物等效性的改进型大样本方法。
J Biopharm Stat. 2000 Nov;10(4):527-44. doi: 10.1081/BIP-100101982.
3
Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.四周期交叉设计中生物等效性评估的替代置信区间
Stat Med. 2002 Jul 15;21(13):1825-47. doi: 10.1002/sim.1151.
4
Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.药品质量研究机构对药用气雾剂级联撞击器图谱的评估。第3部分。关于确定等效性的统计程序的最终报告。
AAPS PharmSciTech. 2007 Nov 2;8(4):E90. doi: 10.1208/pt0804090.
5
Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.参考标度生物等效性半重复方法与其他方法的比较:聚焦于人体药物暴露
Eur J Pharm Sci. 2009 Aug 12;38(1):55-63. doi: 10.1016/j.ejps.2009.05.013. Epub 2009 Jun 11.
6
Assessing individual bioequivalence with high-order cross-over designs: a unified procedure.使用高阶交叉设计评估个体生物等效性:一种统一方法。
Stat Med. 2003 Sep 30;22(18):2847-60. doi: 10.1002/sim.1382.
7
Individual bioequivalence testing under 2x3 designs.2×3设计下的个体生物等效性试验。
Stat Med. 2002 Mar 15;21(5):629-48. doi: 10.1002/sim.1056.
8
Kullback-Leibler divergence for evaluating bioequivalence.用于评估生物等效性的库尔贝克-莱布勒散度
Stat Med. 2003 Mar 30;22(6):913-30. doi: 10.1002/sim.1451.
9
Tests for individual and population bioequivalence based on generalized p-values.基于广义p值的个体和群体生物等效性检验。
Stat Med. 2003 Jan 15;22(1):31-53. doi: 10.1002/sim.1346.
10
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.比较仿制药和创新药:对美国食品药品监督管理局12年生物等效性数据的综述
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.

引用本文的文献

1
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.吸入制剂的体外测试:基于科学的监管方法进展
AAPS J. 2015 Jul;17(4):837-52. doi: 10.1208/s12248-015-9763-3. Epub 2015 May 5.
2
Performance properties of the population bioequivalence approach for in vitro delivered dose for orally inhaled respiratory products.口服吸入式呼吸产品体外递送剂量的群体生物等效性方法的性能特性。
AAPS J. 2014 Jan;16(1):89-100. doi: 10.1208/s12248-013-9543-x. Epub 2013 Nov 19.